John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPTA
Perpetua Resources
PPTA
|
+$102M |
| 2 |
Bausch Health
BHC
|
+$32.6M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$8.96M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$2.98M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$2.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.3% |
| 2 | Materials | 36.53% |
| 3 | Financials | 15.68% |
| 4 | Technology | 3.08% |
| 5 | Industrials | 2.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Madrigal Pharmaceuticals
MDGL
$11.9B
| $632M | 31.44% |
2,089,523
-10,000
| -0.5% | -$2.98M |
|
|
PPTA
2
Perpetua Resources
PPTA
$3.21B
| $393M | 19.53% |
32,347,299
+7,575,757
| +31% | +$102M |
|
|
AAMI
3
Acadian Asset Management
AAMI
$3.28B
| $315M | 15.68% |
8,950,121
| – | – |
|
|
4
Bausch Health
BHC
$2.41B
| $218M | 10.86% |
32,791,702
+6,352,667
| +24% | +$32.6M |
|
5
NovaGold Resources
NG
$3.83B
| $111M | 5.54% |
27,238,061
| – | – |
|
6
Agnico Eagle Mines
AEM
$109B
| $93.2M | 4.63% |
783,561
| – | – |
|
|
THM
7
International Tower Hill Mines
THM
$735M
| $60.1M | 2.99% |
70,239,388
| – | – |
|
8
Thryv Holdings
THRY
$92.4M
| $52M | 2.59% |
4,280,000
| – | – |
|
9
Honeywell
HON
$68.4B
| $46.6M | 2.32% |
212,200
| – | – |
|
|
SA
10
Seabridge Gold
SA
$3.25B
| $30.1M | 1.49% |
2,070,000
| – | – |
|
|
TMQ
11
Trilogy Metals
TMQ
$684M
| $19.3M | 0.96% |
14,326,996
| – | – |
|
12
Equinox Gold
EQX
$15.8B
| $14.4M | 0.71% |
2,500,000
| – | – |
|
13
IAMGOLD
IAG
$12.1B
| $13.6M | 0.68% |
1,850,000
| – | – |
|
|
JNPR
14
DELISTED
Juniper Networks
JNPR
| $9.98M | 0.5% |
+250,000
| New | +$8.96M |
|
|
15
Alphabet (Google) Class C
GOOG
$4.18T
| $1.6M | 0.08% |
+9,000
| New | +$1.49M |
|
|
ITCI
16
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-21,500
| Closed | -$2.84M |
|
Similar funds
John Paulson's Q2 2025 Portfolio in Review
As of Q2 2025, John Paulson held 16 positions worth $2.01B, up 15% from $1.75B the previous quarter. Its ten largest holdings account for 97% of the portfolio.
John Paulson deployed $139M of net new capital in Q2 2025, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Juniper Networks: 250,000 shares worth $9.98M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 50% a quarter earlier, followed by Materials and Financials.
On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $2.98M trimmed.
- John Paulson's largest Q2 2025 buy was Juniper Networks: 250,000 shares worth $9.98M.
- John Paulson added most to Perpetua Resources in Q2 2025, an estimated $102M increase.
- John Paulson's biggest Q2 2025 reduction was Madrigal Pharmaceuticals, cutting an estimated $2.98M.
- John Paulson fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.84M.
- John Paulson's ten largest holdings make up 97% of its $2.01B portfolio in Q2 2025.
- John Paulson opened 2 new positions and closed 1 in Q2 2025.
- John Paulson's portfolio value rose 15% quarter-over-quarter to $2.01B.
Based on Paulson & Co's 13F filing for Q2 2025, filed 14 Aug 2025.